Table 4 Medical consultations, health problems and regarding patients’ views within 40 and 124 days after vaccination (long-term and follow-up surveys)

N

2002

689

192

159

337

5539

1342

471

1382

879

378

Medical consultations (%)

 Outpatient

11.0

11.2

15.1

12.0

11.3

18.4

18.3

15.9

15.8

14.0

19.8

 Outpatient in planning

1.8

2.5

1.0

4.4

2.7

2.6

3.0

2.1

2.5

2.2

1.1

 Inpatient

1.6

1.3

2.6

0.6

2.4

2.5

2.2

2.5

1.1

1.1

2.1

 Inpatient in planning

0.0

0.1

0.0

1.3

0.3

0.4

0.3

0.2

0.4

0.0

0.3

Participants with at least one medical consultation

 %

13.0

13.8

16.7

16.5

14.2

21.4

21.6

18.3

18.4

16.4

20.9

 n

261

95

32

26

48

1183

290

86

254

144

79

thereof:

HPlMC was unknown to the participant prior to vaccination (%)

 All HPlMC

48.7

45.3

68.8

46.2

52.1

51.8

54.1

43.0

49.2

56.9

54.4

 At least one HPlMC

35.2

35.8

31.2

38.5

33.3

34.5

32.4

36.0

34.3

28.5

34.2

Participant suspected association of HPlMC to vaccination (%)

 Regarding all HPlMC

5.0

12.6

3.1

7.7

2.1

2.9

3.8

3.5

2.8

4.2

0.0

 Regarding at least one HPlMC

23.0

17.9

18.8

23.1

6.2

17.7

19.7

10.5

16.1

18.1

8.9

All HPlMC unknown and association with vaccination is suspected by the participant (%)

4.2

9.4

3.1

7.6

2.1

2.4

2.8

2.3

2.4

4.2

0.0

Health problems leading to medical consultation (%)

 Musculoskeletal disorders

36.8

49.5

34.3

41.9

25.0

40.3

38.3

48.7

38.9

38.2

39.2

 General symptoms

42.5

52.6

31.2

38.1

50.0

41.9

46.9

29.0

31.5

36.1

40.5

 Neurological disorders

36.4

44.2

37.4

34.3

29.2

29.2

30.7

26.7

26.0

29.8

29.1

 Cardiovascular disorders

19.2

9.5

18.7

15.2

12.5

15.7

14.1

16.2

10.2

13.2

11.4

 Unsolicited health problems

52.5

55.8

56.1

45.7

56.3

48.9

48.0

54.5

46.8

56.9

57.0

 No health problem named

6.5

6.3

6.2

3.8

6.3

4.7

4.1

3.5

6.7

4.2

2.5